A 60-year-old white female patient sought treatment for asymptomatic erythematous-telangiectasia macules on her upper limbs, back, abdomen, thighs, neck, and lips (Figures 1 and 2 ). The condition started at 7 years of age. Her lower limbs showed no skin alterations, and she never developed mucosal nor visceral bleeding. Darier's sign was negative. She suffered from hypertension and type II diabetes mellitus; atenolol, hydrochlorothiazide, furosemide, and metformin were used for treatment. She denied skin lesions in other family members, including her only daughter. She had quit smoking, had no history of alcohol abuse, and had reached menopause at the age of 45. Histopathological examination performed on her skin (back and left shoulder) showed preserved epidermis, dilated superficial dermal blood vessels, mild lymphocyte reaction, and absence of mast cells (Figure 3 ). Lab tests -e.g., complete blood
tioned findings. Hereditary hemorrhagic telangiectasia is different from BHT, as the capillary walls in the latter get thicker, which explains the absence of hemorrhagic phenomena. 1, 2 Brancati et al. 1 performed a genetic study of an Italian family with 13 members affected by BHT over three generations. Their autosomal dominant inheritance showed complete penetrance, and the study found a genetic variant in the 7Mb region on chromosome 5q14, called CMC1.
As described by Cai et al. 3 and Nakajima et al. 4 , we report a case of BHT without family history, suggesting that this dermatosis might occur sporadically. Luiti et al. 5 have recently reported the first case of BHT in the literature without family history in monozygotic twins.
Due to a lack of resources, our hospital failed to perform a genetic study of this case. Therefore, it is unclear whether a genetic mutation occurred. Despite this fact, our clinical diagnosis remains confirmed. Further studies focusing on the genetic aspect of BHT cases should be performed in order to improve our understanding of its means of transmission.
There is no effective treatment to prevent telangiectasia.
Being a benign condition, presenting no health risks, except for aesthetic nuisance, laser treatments and intense pulsed light are recommended treatments.
